Federated Hermes
DNLI icon

Federated Hermes’s Denali Therapeutics DNLI Stock Holding History

Federated Hermes’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,351,900
Closed -$29M – 2053
2023
Q4 		$29M Hold
1,351,900
– – 0.07% 301
2023
Q3 		$27.9M Buy
1,351,900
+288,400
+27% +$7.32M 0.07% 291
2023
Q2 		$31.4M Hold
1,063,500
– – 0.08% 293
2023
Q1 		$24.5M Buy
1,063,500
+288,500
+37% +$7.94M 0.06% 337
2022
Q4 		$21.6M Buy
775,000
+118,407
+18% +$3.52M 0.06% 365
2022
Q3 		$20.2M Sell
656,593
-12,336
-2% -$401K 0.06% 377
2022
Q2 		$19.7M Sell
668,929
-236,316
-26% -$6.19M 0.05% 395
2022
Q1 		$29.1M Buy
905,245
+169,813
+23% +$5.84M 0.07% 355
2021
Q4 		$32.8M Buy
735,432
+396,272
+117% +$18.8M 0.06% 363
2021
Q3 		$17.1M Buy
339,160
+200,528
+145% +$11.3M 0.03% 516
2021
Q2 		$10.9M Buy
138,632
+8,672
+7% +$536K 0.02% 625
2021
Q1 		$7.42M Sell
129,960
-104,240
-45% -$6.98M 0.01% 744
2020
Q4 		$19.6M Buy
234,200
+106,005
+83% +$6.41M 0.04% 475
2020
Q3 		$4.59M Sell
128,195
-149,268
-54% -$4.5M 0.01% 746
2020
Q2 		$6.71M Buy
+277,463
New +$6.52M 0.02% 632
2019
Q3 		– Sell
-103,755
Closed -$2.15M – 2225
2019
Q2 		$2.15M Buy
103,755
+833
+0.8% +$18.7K 0.01% 1035
2019
Q1 		$2.39M Buy
+102,922
New +$2.15M 0.01% 991

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes's DNLI Position: Q1 2024 in Review

Federated Hermes sold out of Denali Therapeutics (DNLI) in Q1 2024, closing a stake of 1,351,900 shares — an estimated $29M sold.

Federated Hermes first reported a position in DNLI in Q1 2019 and held it in 17 quarters. The position peaked at $32.8M in Q4 2021. 210 funds tracked by Wall St. Rank hold DNLI as of Q1 2024.

  • Federated Hermes reported no remaining Denali Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Federated Hermes sold 1,351,900 Denali Therapeutics shares in Q1 2024, an estimated $29M.
  • Federated Hermes first reported a position in Denali Therapeutics in Q1 2019 and held it in 17 quarters.
  • Federated Hermes's Denali Therapeutics position peaked at $32.8M in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.